SYRE Next Earnings Date Notes

— Spyre Therapeutics (SYRE) is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for chronic inflammatory diseases, centering on inflammatory bowel disease (IBD) like ulcerative colitis & Crohn’s disease. SYRE leverages computational & precision engineering technologies to develop next-generation biologics, with a pipeline that includes differentiated anti-integrin antibodies. As you prepare for the next SYRE earnings call, it’s key to focus not only on standard financial metrics such as cash runway, R&D expenses, and partnership agreements, but also on pipeline progress: updates on clinical trial timelines, data releases, and regulatory interactions matter most for long-term success. Milestones such as first-in-human dosing, proof-of-concept trial results, and IND (Investigational New Drug) submissions are especially relevant to track. Additionally, licensing deals or strategic partnerships can provide insight into external validation and potential non-dilutive funding. The long-term performance of SYRE will be driven by the successful advancement of its lead candidates through clinical stages and towards commercialization, making scientific and regulatory updates disclosed during the call particularly important to follow. The next projected earnings date for SYRE is 11/3/2026 after close (stay tuned for a confirmed earnings date once announced).

SYRE Next Earnings Date FAQ

On this page we presented the SYRE Next Earnings Date information for Spyre Therapeutics along with recent past earnings dates. For Q2 of 2026, SYRE reported earnings of -0.360/share, with the earnings report taking place on 8/4/2026. For Q1 of 2026, SYRE reported earnings of -0.740/share, with the earnings report taking place on 5/5/2026. For Q4 of 2025, SYRE reported earnings of -0.700/share, with the earnings report taking place on 2/19/2026. For Q3 of 2025, SYRE reported earnings of -0.150/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, SYRE reported earnings of -0.490/share, with the earnings report taking place on 8/5/2025. Based on these past earnings dates, the projected next earnings date for SYRE is 11/3/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Spyre Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Spyre Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Spyre Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next SYRE earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up SYRE's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the SYRE next earnings date.